Acetaminophen (ACT), sulfapyridine (SPY), ibuprofen (IBP) and docusate (DCT) are pharmaceuticals with widespread usage that experience incomplete removal in wastewater treatment systems. While further removal of these pharmaceuticals from wastewater effluent is desired prior to beneficial reuse, additional treatment technologies are often expensive and energy intensive. This study evaluated the ability of biochar produced from cotton gin waste (CG700) and walnut shells (WS800) to remove four pharmaceuticals (ACT, SPY, IBP, and DCT) from aqueous solution. Physico-chemical properties of the biochars were characterized by Brunauer-Emmett-Teller (BET) analysis, scanning electron microscopy (SEM), Fourier Transform Infrared Spectroscopy (FT-IR), and zeta potential. The increased pyrolysis temperature during the production of WS800 led to an increase in the specific surface area and increased dehydration of the biochar represented by the loss of the OH-group. Fixed-bed column experiments were performed to determine the difference in removal efficiency between the biochars and elucidate the effects of biochar properties on the adsorption capacity for the pharmaceuticals of interest. Results showed that CG700 had a greater affinity for removing DCT (99%) and IBP (50%), while WS800 removed 72% of SPY and 68% of ACT after 24 h. Adsorption was influenced by the solution pH, surface area, net charge, and functional groups of the biochars. The mechanisms for removal included pore filling and diffusion, hydrophobic interactions, hydrogen bonding, and π-π electron donor acceptor interactions. To conduct predictive modeling of the column breakthrough curves, the Thomas, Adams-Bohart, and Yoon-Nelson models were applied to the experimental data. Results demonstrated that these models generally provided a poor fit for the description of asymmetrical breakthrough curves. Overall, the results demonstrate that biochars from cotton gin waste and walnut shells could be used as cost-effective, environmentally friendly alternatives to activated carbon for the removal of pharmaceuticals from aqueous solutions.

Per‐ and polyfluoroalkyl substances (PFAS) are a collective name for thousands of synthetic compounds produced to enhance consumer and industrial products since the 1940s. They do not easily degrade, and some are known to pose serious ecological and human health concerns at trace concentrations (ng L⁻¹ levels). Per‐ and polyfluoroalkyl substances persist in treated wastewater and are inadvertently introduced into the environment when treated wastewater is reused as an irrigation source. The Pennsylvania State University (PSU) has been spray‐irrigating its wastewater at a 2.45 km² mixed‐use agricultural and forested site known as the “Living Filter” since the 1960s. To understand the spatiotemporal patterns of 20 PFAS at the Living Filter, water samples were collected bimonthly from fall 2019 through winter 2021 from the PSU's wastewater effluent and from each of the site's 13 monitoring wells. Crop tissue was collected at the time of harvest to assess PFAS presence in corn silage and tall fescue grown at the study site. Total measured PFAS concentrations in the monitoring wells ranged from nondectable to 155 ng L⁻¹, with concentrations increasing with the direction of groundwater flow. Concentrations within each well exhibited little temporal variability across sampling events, with mixed relationships between PFAS and groundwater elevation observed between wells. Further, >84% of the PFAS present in livestock feed crops were short‐chain compounds, with PFAS consumed annually by livestock fed crops harvested from the site estimated to be 2.46–7.67 mg animal⁻¹ yr⁻¹. This research provides insight into the potential impacts of long‐term beneficial reuse of treated wastewater on groundwater and crop tissue quality.

During the COVID‐19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community‐scale health. Further, the well‐known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic would increase the concentrations in wastewater treatment plant effluent. We collected weekly influent and effluent samples from May 2020 through May 2021 from two wastewater treatment plants in central Pennsylvania, the Penn State Water Reclamation Facility and the University Area Joint Authority, that provide effluent for beneficial reuse, including for irrigation. Samples were analyzed for severe acute respiratory syndrome coronavirus 2 (influent only), two over‐the‐counter medicines (acetaminophen and naproxen), five antibiotics (ampicillin, doxycycline, ofloxacin, sulfamethoxazole, and trimethoprim), two therapeutic agents (remdesivir and dexamethasone), and hydroxychloroquine. Although there were no correlations between pharmaceutical and virus concentration, remdesivir detection occurred when the number of hospitalized patients with COVID‐19 increased, and dexamethasone detection co‐occurred with the presence of patients with COVID‐19 on ventilators. Additionally, Penn State decision‐making regarding instruction modes explained the temporal variation of influent pharmaceutical concentrations, with detection occurring primarily when students were on campus. Risk quotients calculated for pharmaceuticals with known effective and lethal concentrations at which 50% of a population is affected for fish, daphnia, and algae were generally low in the effluent; however, some acute risks from sulfamethoxazole were high when students returned to campus. Remdesivir and dexamethasone persisted through the wastewater treatment plants, thereby introducing novel pharmaceuticals directly to soils and surface water. These results highlight connections between human health and water quality and further demonstrate the broad utility of wastewater surveillance.

Riparian forest (CP22) buffers are implemented in the Chesapeake Bay Watershed to trap pollutants in surface runoff thus minimizing the amount of pollutants entering the stream network. For these buffers to function effectively, overland flow must enter the riparian zones as dispersed sheet flow to facilitate slowing, filtering, and infiltrating of surface runoff. The occurrence of concentrated flowpaths, however, is prevalent across the watershed. Concentrated flowpaths limit buffer filtration capacity by channeling overland flow through or around buffers. In this study, two topographic metrics (topographic openness and flow accumulation) were used to evaluate the occurrence of concentrated flowpaths and to derive effective CP22 contributing areas in four Long-Term Agroecosystem Research (LTAR) watersheds within the Chesapeake Bay Watershed. The study watersheds include the Tuckahoe Creek watershed (TCW) located in Maryland, and the Spring Creek (SCW), Conewago Creek (CCW) and Mahantango Creek (MCW) watersheds located in Pennsylvania. Topographic openness identified detailed topographic variation and critical source areas in the lower relief areas while flow accumulation was better at identifying concentrated flowpaths in higher relief areas. Results also indicated that concentrated flowpaths are prevalent across all four watersheds, reducing CP22 effective contributing areas by 78% in the TCW, 54% in the SCW, 38% in the CCW and 22% in the MCW. Thus, to improve surface water quality within the Chesapeake Bay Watershed, the implementation of riparian forest buffers should be done in such a way as to mitigate the effects of concentrated flowpaths that continue to short-circuit these buffers.